BioSculpture Technology careers

BST’s Corporate Mission is to be a world leading manufacturer and developer of medical devices and procedures for handling adipose tissue targeting:
· the liposuction and body sculpting market;
· the bariatric market; and
· fat autograft and adipocyte-derived stem cell processing markets.
BSt's Obesity Control Division is developing minimally invasive devices for the endoscopic removal of visceral or "belly" fat based on our 3 recently allowed US patents and EPO application. This now possible surgical alternative to current bariatric surgical alternatives for obesity, metabolic syndrome, and type 2 diabetes will be safer as it does not require cutting into the stomach, bowel, rearranging the body's alimentary plumbing, or leaving behind a foreign body. And it can repeated to avoid a weight loss plateau and is expected to be highly effective to obtain the results of surgery without its risks, sequelae or costs.